Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lauren Harshman
ECOG-ACRIN Cancer Research Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
413 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arthur J E Child Comprehensive Cancer Centre
Calgary, Alberta, Canada
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- the Moncton Hospital
Moncton, New Brunswick, Canada
- Qeii Health Sciences Centre/nova Scotia Health Authority
Halifax, Nova Scotia, Canada
- Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Saint Joseph'S Healthcare Charlton Campus
Hamilton, Ontario, Canada
- Kingston Health Sciences Centre
Kingston, Ontario, Canada
- London Regional Cancer Program
London, Ontario, Canada
- Niagara Health System-Saint Catharines General
Saint Catharines, Ontario, Canada
- Odette Cancer Centre- Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
- University Health Network-Princess Margaret Hospital
Toronto, Ontario, Canada
- Windsor Regional Cancer Centre
Windsor, Ontario, Canada
- Chum - Centre Hospitalier de L'Universite de Montreal
Montreal, Quebec, Canada
- Centre Hospitalier Universitaire de Sherbrooke-Fleurimont
Sherbrooke, Quebec, Canada
- Rambam Medical Center
Haifa, Israel
- Shaare Zedek Medical Center
Jerusalem, Israel
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Veterans Administration Medical Center - Birmingham
Birmingham, Alabama, United States
- Banner Md Anderson Cancer Center
Gilbert, Arizona, United States
- Cancer Center at Saint Joseph'S
Phoenix, Arizona, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- Kaiser Permanente-Anaheim
Anaheim, California, United States
- Sutter Auburn Faith Hospital
Auburn, California, United States
- Ais Cancer Center at San Joaquin Community Hospital
Bakersfield, California, United States
- Kaiser Permanente-Baldwin Park
Baldwin Park, California, United States
- Kaiser Permanente-Bellflower
Bellflower, California, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Mills-Peninsula Medical Center
Burlingame, California, United States
- Community Cancer Institute
Clovis, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Kaiser Permanente-Fontana
Fontana, California, United States
- Kaiser Permanente South Bay
Harbor City, California, United States
- Kaiser Permanente-Irvine
Irvine, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
- Kaiser Permanente West Los Angeles
Los Angeles, California, United States
- Ucla / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Apr 2017
- Primary completion
- 24 May 2023
- Completion
- 9 Jun 2031
- Last update posted
- 2 Jul 2026
- Registered enrollment
- 819
- Registry id
- NCT03055013
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.